Found: 47
Select item for more details and to access through your institution.
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 2, p. 233, doi. 10.1007/s00262-007-0370-8
- By:
- Publication type:
- Article
Editorial: Effector functions of therapeutic antibodies.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 1, doi. 10.3389/fimmu.2022.1126966
- By:
- Publication type:
- Article
Dual Fc optimization to increase the cytotoxic activity of a CD19-targeting antibody.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 01, doi. 10.3389/fimmu.2022.957874
- By:
- Publication type:
- Article
The relevance of complement in pemphigoid diseases: A critical appraisal.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.973702
- By:
- Publication type:
- Article
Myeloid checkpoint blockade improves killing of T-acute lymphoblastic leukemia cells by an IgA2 variant of daratumumab.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.949140
- By:
- Publication type:
- Article
Identification of New Antibodies Targeting Malignant Plasma Cells for Immunotherapy by Next-Generation Sequencing-Assisted Phage Display.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.908093
- By:
- Publication type:
- Article
NKp46‐specific single domain antibodies enable facile engineering of various potent NK cell engager formats.
- Published in:
- Protein Science: A Publication of the Protein Society, 2023, v. 32, n. 3, p. 1, doi. 10.1002/pro.4593
- By:
- Publication type:
- Article
Prosaposin hyperglycosylation: a novel tumor immune escape mechanism and implications for cancer immunotherapy.
- Published in:
- Signal Transduction & Targeted Therapy, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41392-024-01877-2
- By:
- Publication type:
- Article
FcγRIIIb Restricts Antibody-Dependent Destruction of Cancer Cells by Human Neutrophils.
- Published in:
- Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2018.03124
- By:
- Publication type:
- Article
Tribody [(HER2)<sub>2</sub>xcD16] is More Effective Than Trastuzumab in Enhancing γδ T Cell and Natural Killer Cell Cytotoxicity Against HER2-Expressing Cancer Cells.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00814
- By:
- Publication type:
- Article
Inhibition of the JAK-STAT3-Mcl-1 Axis by Combining Ruxolitinib with S63845 Completely Prevents Plasmacytoma Growth in the Gp130-Regulated INA-6 Xenograft Mouse Model.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e129, doi. 10.1016/j.clml.2019.09.214
- By:
- Publication type:
- Article
Potent Targeting of the Glycoantigen CD75s on Myeloma by the Tetravalent, Fc-Engineered Antibody 'EBU-141 Tetra'.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e17, doi. 10.1016/j.clml.2019.09.025
- By:
- Publication type:
- Article
Impact of Human IgA Antibodies on Complement-Dependent Cytotoxicity Mediated by Combinations of EGF-R-Directed Antibodies.
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2010, v. 58, n. 4, p. 303, doi. 10.1007/s00005-010-0081-2
- By:
- Publication type:
- Article
An IgG3 switch variant of rituximab mediates enhanced complement-dependent cytotoxicity against tumour cells with low CD20 expression levels.
- Published in:
- British Journal of Haematology, 2013, v. 161, n. 2, p. 282, doi. 10.1111/bjh.12209
- By:
- Publication type:
- Article
A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells.
- Published in:
- British Journal of Haematology, 2006, v. 133, n. 2, p. 141, doi. 10.1111/j.1365-2141.2005.05869.x
- By:
- Publication type:
- Article
Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and Fc γRIII (CD16).
- Published in:
- British Journal of Haematology, 2005, v. 130, n. 2, p. 218, doi. 10.1111/j.1365-2141.2005.05414.x
- By:
- Publication type:
- Article
research paper A recombinant bispecific single-chain Fv antibody against HLA class II and FcγRIII (CD16) triggers effective lysis of lymphoma cells.
- Published in:
- British Journal of Haematology, 2004, v. 125, n. 2, p. 167, doi. 10.1111/j.1365-2141.2004.04893.x
- By:
- Publication type:
- Article
Monitoring circulating γδT cells in cancer patients to optimize γδT cell-based immunotherapy.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00643
- By:
- Publication type:
- Article
γδ T cell-mediated antibody-dependent cellular cytotoxicity with CD19 antibodies assessed by an impedance-based label-free real-time cytotoxicity assay.
- Published in:
- Frontiers in Immunology, 2014, v. 5, p. 1, doi. 10.3389/fimmu.2014.00618
- By:
- Publication type:
- Article
Ig A EGFR antibodies mediate tumour killing in vivo.
- Published in:
- EMBO Molecular Medicine, 2013, v. 5, n. 8, p. 1213, doi. 10.1002/emmm.201201929
- By:
- Publication type:
- Article
Enhanced ADCC Activity of Affinity Maturated and Fc-Engineered Mini- Antibodies Directed against the AML Stem Cell Antigen CD96.
- Published in:
- PLoS ONE, 2012, v. 7, n. 8, p. 1, doi. 10.1371/journal.pone.0042426
- By:
- Publication type:
- Article
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity.
- Published in:
- 2018
- By:
- Publication type:
- Letter to the Editor
Tumor cell lysis and synergistically enhanced antibody-dependent cell-mediated cytotoxicity by NKG2D engagement with a bispecific immunoligand targeting the HER2 antigen.
- Published in:
- Biological Chemistry, 2022, v. 403, n. 5/6, p. 545, doi. 10.1515/hsz-2021-0229
- By:
- Publication type:
- Article
ADAM17-overexpressing breast cancer cells selectively targeted by antibody-toxin conjugates.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 3, p. 411, doi. 10.1007/s00262-012-1346-x
- By:
- Publication type:
- Article
Enhancing CDC and ADCC of CD19 Antibodies by Combining Fc Protein-Engineering with Fc Glyco-Engineering.
- Published in:
- Antibodies (2073-4468), 2020, v. 9, n. 4, p. 63, doi. 10.3390/antib9040063
- By:
- Publication type:
- Article
Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1286097
- By:
- Publication type:
- Article
Novel NKG2D-directed bispecific antibodies enhance antibodymediated killing of malignant B cells by NK cells and T cells.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1227572
- By:
- Publication type:
- Article
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
- Published in:
- Frontiers in Immunology, 2023, p. 01, doi. 10.3389/fimmu.2023.1178817
- By:
- Publication type:
- Article
Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma.
- Published in:
- Cancers, 2021, v. 13, n. 12, p. 3072, doi. 10.3390/cancers13123072
- By:
- Publication type:
- Article
Bispecific antibodies enhance tumor‐infiltrating T cell cytotoxicity against autologous HER‐2‐expressing high‐grade ovarian tumors.
- Published in:
- Journal of Leukocyte Biology, 2020, v. 107, n. 6, p. 1081, doi. 10.1002/JLB.5MA1119-265R
- By:
- Publication type:
- Article
Antibody Engineering – Tailor-Made Next Generation Antibodies by Molecular Design.
- Published in:
- Transfusion Medicine & Hemotherapy, 2017, v. 44, n. 5, p. 290, doi. 10.1159/000479617
- By:
- Publication type:
- Article
Modulating Cytotoxic Effector Functions by Fc Engineering to Improve Cancer Therapy.
- Published in:
- Transfusion Medicine & Hemotherapy, 2017, v. 44, n. 5, p. 327, doi. 10.1159/000479980
- By:
- Publication type:
- Article
An Fc Double-Engineered CD20 Antibody with Enhanced Ability to Trigger Complement-Dependent Cytotoxicity and Antibody-Dependent Cell-Mediated Cytotoxicity.
- Published in:
- Transfusion Medicine & Hemotherapy, 2017, v. 44, n. 5, p. 292, doi. 10.1159/000479978
- By:
- Publication type:
- Article
Engineering of CD19 Antibodies: A CD19-TRAIL Fusion Construct Specifically Induces Apoptosis in B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Cells In Vivo.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 12, p. 2634, doi. 10.3390/jcm10122634
- By:
- Publication type:
- Article
Galectin-3 Released by Pancreatic Ductal Adenocarcinoma Suppresses γδ T Cell Proliferation but Not Their Cytotoxicity.
- Published in:
- Frontiers in Immunology, 2020, p. 1, doi. 10.3389/fimmu.2020.01328
- By:
- Publication type:
- Article
TRAIL-Receptor 4 Modulates γδ T Cell-Cytotoxicity Toward Cancer Cells.
- Published in:
- Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02044
- By:
- Publication type:
- Article
Optimised protocols for RNA extraction from a broad taxonomic range of algae.
- Published in:
- Journal of Applied Phycology, 2023, v. 35, n. 4, p. 1743, doi. 10.1007/s10811-023-02980-7
- By:
- Publication type:
- Article
Isolation of polyphenols with anticancer activity from the Baltic Sea brown seaweed Fucus vesiculosus using bioassay-guided fractionation.
- Published in:
- Journal of Applied Phycology, 2017, v. 29, n. 4, p. 2021, doi. 10.1007/s10811-017-1080-z
- By:
- Publication type:
- Article
Complement-Dependent Activity of CD20-Specific IgG Correlates With Bivalent Antigen Binding and C1q Binding Strength.
- Published in:
- Frontiers in Immunology, 2021, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.609941
- By:
- Publication type:
- Article
Specific Targeting of Lymphoma Cells Using Semisynthetic Anti-Idiotype Shark Antibodies.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.560244
- By:
- Publication type:
- Article
Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 11, p. 2001, doi. 10.1093/neuonc/noad108
- By:
- Publication type:
- Article
Combining Cellular Immunization and Phage Display Screening Results in Novel, FcγRI-Specific Antibodies.
- Published in:
- Viruses (1999-4915), 2024, v. 16, n. 4, p. 596, doi. 10.3390/v16040596
- By:
- Publication type:
- Article
Antibody-Dependent Cellular Cytotoxicity in Patients on Chronic Hemodialysis.
- Published in:
- American Journal of Nephrology, 2013, v. 38, n. 5, p. 379, doi. 10.1159/000355972
- By:
- Publication type:
- Article
Molecular Mechanisms by Which a Fucus vesiculosus Extract Mediates Cell Cycle Inhibition and Cell Death in Pancreatic Cancer Cells.
- Published in:
- Marine Drugs, 2015, v. 13, n. 7, p. 4470, doi. 10.3390/md13074470
- By:
- Publication type:
- Article
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.
- Published in:
- Cancer Science, 2021, v. 112, n. 8, p. 3029, doi. 10.1111/cas.14999
- By:
- Publication type:
- Article
Complement-mediated tumor-specific cell lysis by antibody combinations targeting epidermal growth factor receptor (EGFR) and its variant III (EGFRvIII).
- Published in:
- Cancer Science, 2011, v. 102, n. 10, p. 1761, doi. 10.1111/j.1349-7006.2011.02019.x
- By:
- Publication type:
- Article
Fc-engineered EGF-R antibodies mediate improved antibody-dependent cellular cytotoxicity (ADCC) against KRAS-mutated tumor cells.
- Published in:
- Cancer Science, 2010, v. 101, n. 5, p. 1080, doi. 10.1111/j.1349-7006.2010.01505.x
- By:
- Publication type:
- Article